CVE-2023-40355
MEDIUM EPSS 61.2%
Published Feb 7, 20242y ago · Modified Jun 17, 20262w ago
5.4 CVSS 3.1
Published Feb 7, 2024 2y ago
Last Modified Jun 17, 2026 2w ago
Description
Cross Site Scripting (XSS) vulnerability in Axigen versions 10.3.3.0 before 10.3.3.59, 10.4.0 before 10.4.19, and 10.5.0 before 10.5.5, allows authenticated attackers to execute arbitrary code and obtain sensitive information via the logic for switching between the Standard and Ajax versions.
CVSS Details
Base Score
Exploitability
Impact
Vector string
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N Attack Vector Network
Attack Complexity Low
Privileges Required Low
User Interaction Required
Scope Changed
Confidentiality Low
Integrity Low
Availability None
Threat Intelligence
EPSS Exploit Probability
61.2% percentile
Exploit & Patch Status
No Known Exploit
No Patch Available
Weaknesses 1
CWE-79 Cross-site Scripting Injection
Affected Products 3
References 1
- axigen.com https://www.axigen.com/knowledgebase/Axigen-WebMail-XSS-Vulnerability-CVE-2023-40355-_396.html
Remediation
No remediation data recorded yet
Check vendor advisories and the NVD entry for patch availability.